Results 81 to 90 of about 117,754 (162)

Real-World PSA Response and Safety Outcomes of 177Lu-PSMA-617 in Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer: A Single-Center Retrospective Validation Study. [PDF]

J Clin Med
Choi JH, Kim CG, Oh KT, Heo JE, Lee J, Jang WS, Lee SH, Choi YD, Beom SH, Kang WJ, Han WK, Han H.   +11 more
europepmc   +1 more source

Case Report: Clinicopathologic and molecular characteristics of prostate adenocarcinoma brain metastases despite disproportionately low PSA levels: a four-patient case series and narrative review. [PDF]

Front Oncol
Bardhan R, Myint ZW, Kapoor H, Selene I.
europepmc   +1 more source

Serum [-2]proPSA as a Candidate Phenotypic Correlate of Molecular Alterations and Prognostic Marker in Metastatic Castration-Resistant Prostate Cancer. [PDF]

Prostate Cancer
Conteduca V, Garofoli M, Bruno G, Landriscina M, Fiorenza M, Polito C, Sirica R, Terracciano D.   +7 more
europepmc   +1 more source

Exceptional long-term responses in metastatic androgen pathway-modulation sensitive prostate cancer. [PDF]

Oncologist
Nandakumar V, Gebrael G, Agarwal N.
europepmc   +1 more source

Extracapsular and joint-dominant hand and wrist MRI patterns in psoriatic and rheumatoid arthritis: an exploratory case-control study. [PDF]

Front Immunol
Huang J, Song S, Zhang Q, Fan Q, Li Y, Peng Y, Zhu Y, Hu G, Yu L, Chen J, Chen L, Xia P, Chen J.   +12 more
europepmc   +1 more source

The Role of Dominant Lesion Site and SUVmax in the Depth of PSA Response in Metastatic Hormone-Sensitive Prostate Cancer. [PDF]

Biomedicines
Akgüner G, Güleşen Aİ, Yıldırım ÖA.   +2 more
europepmc   +1 more source

Does weather matter? Exploring associations between season and meteorological factors and psoriatic arthritis disease activity. [PDF]

RMD Open
Hojeij B, Luime JJ, Bos R, Korswagen LA, Vis M, Bijsterbosch J, Baudoin P, Van Der Kaap JH, Kok P, Goekoop-Ruiterman Y, Kok MR, Tchetverikov I.   +11 more
europepmc   +1 more source